Medical - Healthcare Information Services
Compare Stocks
2 / 10Stock Comparison
HTFL vs ISRG
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Instruments & Supplies
HTFL vs ISRG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Healthcare Information Services | Medical - Instruments & Supplies |
| Market Cap | $11.16B | $160.44B |
| Revenue (TTM) | $176M | $10.58B |
| Net Income (TTM) | $-117M | $2.98B |
| Gross Margin | 92.7% | 66.3% |
| Operating Margin | -36.4% | 30.5% |
| Forward P/E | — | 43.7x |
| Total Debt | $22M | $303M |
| Cash & Equiv. | $45M | $3.37B |
Quick Verdict: HTFL vs ISRG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HTFL is the clearest fit if your priority is growth exposure.
- Rev growth 39.9%, EPS growth 8.1%
- 39.9% revenue growth vs ISRG's 20.5%
- +5.4% vs ISRG's -14.8%
ISRG carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- beta 1.02
- 5.6% 10Y total return vs HTFL's 5.4%
- Lower volatility, beta 1.02, Low D/E 1.7%, current ratio 4.87x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 39.9% revenue growth vs ISRG's 20.5% | |
| Quality / Margins | 28.2% margin vs HTFL's -66.3% | |
| Stability / Safety | Beta 1.02 vs HTFL's 2.00, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +5.4% vs ISRG's -14.8% | |
| Efficiency (ROA) | 14.8% ROA vs HTFL's -43.8%, ROIC 15.0% vs -17.3% |
HTFL vs ISRG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
HTFL vs ISRG — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — HTFL and ISRG each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ISRG is the larger business by revenue, generating $10.6B annually — 60.1x HTFL's $176M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to HTFL's -66.3%. On growth, HTFL holds the edge at +40.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $176M | $10.6B |
| EBITDAEarnings before interest/tax | -$55M | $3.8B |
| Net IncomeAfter-tax profit | -$117M | $3.0B |
| Free Cash FlowCash after capex | -$59M | $2.8B |
| Gross MarginGross profit ÷ Revenue | +92.7% | +66.3% |
| Operating MarginEBIT ÷ Revenue | -36.4% | +30.5% |
| Net MarginNet income ÷ Revenue | -66.3% | +28.2% |
| FCF MarginFCF ÷ Revenue | -33.5% | +26.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +40.5% | +23.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +51.9% | +18.8% |
Valuation Metrics
ISRG leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $11.2B | $160.4B |
| Enterprise ValueMkt cap + debt − cash | $11.1B | $157.4B |
| Trailing P/EPrice ÷ TTM EPS | -22.11x | 57.40x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 43.67x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.64x |
| EV / EBITDAEnterprise value multiple | — | 43.44x |
| Price / SalesMarket cap ÷ Revenue | 63.41x | 15.94x |
| Price / BookPrice ÷ Book value/share | 37.13x | 9.13x |
| Price / FCFMarket cap ÷ FCF | — | 64.42x |
Profitability & Efficiency
ISRG leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-39 for HTFL. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to HTFL's 0.07x. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs HTFL's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -38.8% | +16.9% |
| ROA (TTM)Return on assets | -43.8% | +14.8% |
| ROICReturn on invested capital | -17.3% | +15.0% |
| ROCEReturn on capital employed | -31.9% | +16.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.07x | 0.02x |
| Net DebtTotal debt minus cash | -$23M | -$3.1B |
| Cash & Equiv.Liquid assets | $45M | $3.4B |
| Total DebtShort + long-term debt | $22M | $303M |
| Interest CoverageEBIT ÷ Interest expense | -4.71x | — |
Total Returns (Dividends Reinvested)
ISRG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ISRG five years ago would be worth $16,086 today (with dividends reinvested), compared to $10,536 for HTFL. Over the past 12 months, HTFL leads with a +5.4% total return vs ISRG's -14.8%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.2% vs HTFL's 1.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +4.6% | -19.6% |
| 1-Year ReturnPast 12 months | +5.4% | -14.8% |
| 3-Year ReturnCumulative with dividends | +5.4% | +49.0% |
| 5-Year ReturnCumulative with dividends | +5.4% | +60.9% |
| 10-Year ReturnCumulative with dividends | +5.4% | +556.9% |
| CAGR (3Y)Annualised 3-year return | +1.8% | +14.2% |
Risk & Volatility
ISRG leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ISRG is the less volatile stock with a 1.02 beta — it tends to amplify market swings less than HTFL's 2.00 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.00x | 1.02x |
| 52-Week HighHighest price in past year | $41.22 | $603.88 |
| 52-Week LowLowest price in past year | $20.13 | $427.84 |
| % of 52W HighCurrent price vs 52-week peak | +73.5% | +74.8% |
| RSI (14)Momentum oscillator 0–100 | 55.2 | 42.2 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 1.8M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates HTFL as "Buy" and ISRG as "Buy". Consensus price targets imply 37.8% upside for ISRG (target: $623) vs 25.5% for HTFL (target: $38).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $38.00 | $622.60 |
| # AnalystsCovering analysts | 4 | 55 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.4% |
ISRG leads in 4 of 6 categories — strongest in Valuation Metrics and Profitability & Efficiency. 1 category is tied.
HTFL vs ISRG: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is HTFL or ISRG a better buy right now?
For growth investors, Heartflow, Inc.
Common Stock (HTFL) is the stronger pick with 39. 9% revenue growth year-over-year, versus 20. 5% for Intuitive Surgical, Inc. (ISRG). Intuitive Surgical, Inc. (ISRG) offers the better valuation at 57. 4x trailing P/E (43. 7x forward), making it the more compelling value choice. Analysts rate Heartflow, Inc. Common Stock (HTFL) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — HTFL or ISRG?
Over the past 5 years, Intuitive Surgical, Inc.
(ISRG) delivered a total return of +60. 9%, compared to +5. 4% for Heartflow, Inc. Common Stock (HTFL). Over 10 years, the gap is even starker: ISRG returned +556. 9% versus HTFL's +5. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — HTFL or ISRG?
By beta (market sensitivity over 5 years), Intuitive Surgical, Inc.
(ISRG) is the lower-risk stock at 1. 02β versus Heartflow, Inc. Common Stock's 2. 00β — meaning HTFL is approximately 96% more volatile than ISRG relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 7% for Heartflow, Inc. Common Stock — giving it more financial flexibility in a downturn.
04Which is growing faster — HTFL or ISRG?
By revenue growth (latest reported year), Heartflow, Inc.
Common Stock (HTFL) is pulling ahead at 39. 9% versus 20. 5% for Intuitive Surgical, Inc. (ISRG). On earnings-per-share growth, the picture is similar: Intuitive Surgical, Inc. grew EPS 22. 6% year-over-year, compared to 8. 1% for Heartflow, Inc. Common Stock. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — HTFL or ISRG?
Intuitive Surgical, Inc.
(ISRG) is the more profitable company, earning 28. 4% net margin versus -66. 3% for Heartflow, Inc. Common Stock — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -36. 4% for HTFL. At the gross margin level — before operating expenses — HTFL leads at 76. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is HTFL or ISRG more undervalued right now?
Analyst consensus price targets imply the most upside for ISRG: 37.
8% to $622. 60.
07Which pays a better dividend — HTFL or ISRG?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is HTFL or ISRG better for a retirement portfolio?
For long-horizon retirement investors, Intuitive Surgical, Inc.
(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02), +556. 9% 10Y return). Heartflow, Inc. Common Stock (HTFL) carries a higher beta of 2. 00 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ISRG: +556. 9%, HTFL: +5. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between HTFL and ISRG?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.